Enliven Therapeutics ELVN
NASDAQ ELVN
$45.87 -0.64 (-1.38%)
As of: Sep 30, 2026 · 2:59 PM EDT

Enliven Therapeutics (ELVN) Current Taxes (2024)

Updated

Enliven Therapeutics' Current Taxes came in at $232,000 for Q2 2024.

Analysis

Enliven Therapeutics (ELVN) Current Taxes (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.05 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 4.22 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 2.31 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -1.47 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 653.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Enliven Therapeutics 3.41 Bn 3.41 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 232,000.00
API Access

Enliven Therapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=ELVN&period=max&api_key=YOUR_API_KEY